Market revenue in 2024 | USD 11.7 million |
Market revenue in 2030 | USD 32.0 million |
Growth rate | 18.7% (CAGR from 2025 to 2030) |
Largest segment | Proteomic testing |
Fastest growing segment | Metabolomic Testing |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Proteomic Testing, Metabolomic Testing, Genomic Testing |
Key market players worldwide | Abbott Laboratories, Danaher Corp, Siemens Healthineers AG ADR, Roche, QuidelOrtho Corp, BioMerieux SA, Trinity Biotech PLC ADR, Abaxis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heart failure poc & loc devices market will help companies and investors design strategic landscapes.
Proteomic testing was the largest segment with a revenue share of 59.83% in 2024. Horizon Databook has segmented the Asia Pacific heart failure poc & loc devices market based on proteomic testing, metabolomic testing, genomic testing covering the revenue growth of each sub-segment from 2018 to 2030.
Lack of knowledge about prevalence of heart failure has resulted in less revenue share of Asian market in the past years. To curb the healthcare expenditure due to heart failure cases in the country, strategic attempts are being undertaken to raise awareness in the region.
The study concluded that POC coordinator certification and financial support would enhance management of patients cost-effectively. Moreover, training young healthcare personnel about POC cardiac troponin T/cardiac troponin I biomarkers tests in the region would help in efficient decision-making, especially in emergency rooms.
In addition, in June 2014, a POC testing workshop was conducted at the WONCA Special Interest Group on Global Point-ofCare Testing, a WONCA Asia Pacific Regional Conference. The workshop was attended by participants from Malaysia, Brunei, Indonesia, Australia, Hong Kong, Japan, and Nigeria. Such workshops are anticipated to boost regional market share by accelerating the adoption of POC devices across Asian countries.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific heart failure poc & loc devices market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific heart failure poc & loc devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account